1. European Medicines Agency. Guideline on similar biological medicinal products [Internet] [cited 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_gui deline/2009/09/WC500003517.pdf. 2005.
2. World Health Organization. Guidelines on evaluation of similar biotherapeutic products (SBPs) [Internet]. 2009 [cited 2018 Apr 24]. http://www.who.int/biologicals/areas/biological_therapeutics/BIOTHERAPEUTICS_FOR_WEB_22APRIL2010.pdf.
3. Regulatory considerations in oncologic biosimilar drug development
4. European Medicines Agency. Refusal assessment report for Alpheon [Internet] [cited 2017 Aug 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000585/WC500070792.pdf.
5. European Medicines Agency. Withdrawal Assessment Report. Insulin human [Internet] [cited 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/2013/02/WC500138884.pdf.